86 related articles for article (PubMed ID: 30307052)
21. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
[TBL] [Abstract][Full Text] [Related]
23. Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway.
Zhou Q; Wang X; Yu Z; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
Oncogene; 2017 Mar; 36(13):1873-1886. PubMed ID: 27694893
[TBL] [Abstract][Full Text] [Related]
24. Expression of RAP1B is associated with poor prognosis and promotes an aggressive phenotype in gastric cancer.
Yang Y; Li M; Yan Y; Zhang J; Sun K; Qu JK; Wang JS; Duan XY
Oncol Rep; 2015 Nov; 34(5):2385-94. PubMed ID: 26329876
[TBL] [Abstract][Full Text] [Related]
25. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.
Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological significance of MMP-7, laminin γ2 and EGFR expression at the invasive front of gastric carcinoma.
Sentani K; Matsuda M; Oue N; Uraoka N; Naito Y; Sakamoto N; Yasui W
Gastric Cancer; 2014; 17(3):412-22. PubMed ID: 24048760
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical classification of gastric cancer based on new molecular biomarkers: a potential predictor of survival.
Díaz Del Arco C; Estrada Muñoz L; Molina Roldán E; Cerón Nieto MÁ; Ortega Medina L; García Gómez de Las Heras S; Fernández Aceñero MJ
Virchows Arch; 2018 Dec; 473(6):687-695. PubMed ID: 30140949
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma.
Wang W; Chen XL; Zhao SY; Xu YH; Zhang WH; Liu K; Chen XZ; Yang K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
Oncotarget; 2016 Jun; 7(23):35423-36. PubMed ID: 27097114
[TBL] [Abstract][Full Text] [Related]
30. Presence of cancer cells in gastric lavage of gastric cancer patients as an indicator of advanced disease, predictor of tumour aggressive phenotype and independent prognostic factor for poor survival: The endoluminal metastatic pathway of gastric cancer and GL0/GL1 classification.
Virgilio E; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Nigri G; Mercantini P; Ramacciato G; Cavallini M; Balducci G
Cytopathology; 2018 Feb; 29(1):41-48. PubMed ID: 29063636
[TBL] [Abstract][Full Text] [Related]
31. The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas.
Paliga A; Marginean H; Tessier-Cloutier B; Purgina B; Jonker D; Marginean EC
Am J Clin Oncol; 2017 Dec; 40(6):543-551. PubMed ID: 26125303
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
[TBL] [Abstract][Full Text] [Related]
33. Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer.
Jang BG; Lee BL; Kim WH
Virchows Arch; 2015 Sep; 467(3):285-94. PubMed ID: 26070873
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of clinicopathological features and prognosis analysis between carcinoma in the remnant stomach and gastric cancer].
Li F; Wang Y; Li C; Ma Y; Zhang Y; Li Z; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):529-534. PubMed ID: 29774934
[TBL] [Abstract][Full Text] [Related]
35. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
36. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor γ upregulates galectin-9 and predicts prognosis in intestinal-type gastric cancer.
Cho SJ; Kook MC; Lee JH; Shin JY; Park J; Bae YK; Choi IJ; Ryu KW; Kim YW
Int J Cancer; 2015 Feb; 136(4):810-20. PubMed ID: 24976296
[TBL] [Abstract][Full Text] [Related]
38. Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.
Aydin D; Bilici A; Kayahan S; Yavuzer D; Basar M; Aliustaoglu M
Clin Transl Oncol; 2016 Jun; 18(6):608-16. PubMed ID: 26459248
[TBL] [Abstract][Full Text] [Related]
39. Relationship between expression of NADPH oxidase 2 and invasion and prognosis of human gastric cancer.
Wang P; Shi Q; Deng WH; Yu J; Zuo T; Mei FC; Wang WX
World J Gastroenterol; 2015 May; 21(20):6271-9. PubMed ID: 26034362
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.
Chen S; Hou JH; Feng XY; Zhang XS; Zhou ZW; Yun JP; Chen YB; Cai MY
J Surg Oncol; 2013 Jun; 107(8):799-806. PubMed ID: 23609373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]